Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Kisspeptin receptor (Kiss1r), also known as GPR54, is a G protein-coupled receptor that plays a fundamental role in the neuroendocrine control of reproduction in rats [1, 4]. It is primarily expressed on gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus, where its activation by endogenous kisspeptin ligands triggers the release of GnRH [3, 6]. This signaling pathway is the primary driver for the onset of puberty and the maintenance of the hypothalamic-pituitary-gonadal (HPG) axis, regulating the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) [9, 13]. Beyond its reproductive functions, Kiss1r was originally identified as a metastasis suppressor and is involved in regulating metabolic processes such as insulin secretion and glucose homeostasis [3, 8]. Dysregulation of the Kiss1r system is linked to clinical conditions such as hypogonadotropic hypogonadism, precocious puberty, and certain hormone-sensitive cancers [4, 11]. Pharmacological agents targeting Kiss1r, including potent agonists like MVT-602 and antagonists like Peptide 234, are being explored for applications in treating infertility, managing sex steroid-dependent diseases, and potentially controlling tumor progression [3, 19]. However, therapeutic use must account for receptor desensitization, which can lead to the suppression of the reproductive axis during chronic administration [18].
Agonism of the Kiss1r receptor stimulates the hypothalamic-pituitary-gonadal axis by inducing GnRH release, while antagonism or chronic desensitization inhibits this axis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kisspeptin receptor (Kiss1r) (Kiss1r).